Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH. (Q43969516)

28 November 2017

title

Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH. (English)

1 reference

28 November 2017

1 reference

8

1 reference

28 November 2017

1

David Basketter

1 reference

28 November 2017

Nicholas Ball

2

1 reference

28 November 2017

Stuart Cagen

3

1 reference

28 November 2017

Juan-Carlos Carrillo

4

1 reference

28 November 2017

Hans Certa

5

1 reference

28 November 2017

Dorothea Eigler

6

1 reference

28 November 2017

Christine Garcia

7

1 reference

28 November 2017

Cynthia Graham

9

1 reference

28 November 2017

Carl Haux

10

1 reference

28 November 2017

Reinhard Kreiling

11

1 reference

28 November 2017

Annette Mehling

12

1 reference

28 November 2017

language of work or name

English

0 references

publication date

10 June 2009

1 reference

Regulatory Toxicology and Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

55

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

90-96

1 reference

Allergic contact dermatitis from oleyl alcohol in Elidel cream

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Skin sensitization: strategies for the assessment and management of risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Information derived from sensitization test methods: test sensitivity, false positives and false negatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Strategies for identifying false positive responses in predictive skin sensitization tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Identification and classification of skin sensitizers: identifying false positives and false negatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Does irritation potency contribute to the skin sensitization potency of contact allergens?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The local lymph node assay and the assessment of relative potency: status of validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

B220 analysis with the local lymph node assay: proposal for a more flexible prediction model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

DELAYED CONTACT HYPERSENSITIVITY IN THE GUINEA PIG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

7 Final Report on the Safety Assessment of Sodium Lauryl Sulfate and Ammonium Lauryl Sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The local lymph node assay in practice: a current regulatory perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The value and limitations of rechallenge in the guinea pig maximization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Patch testing with myristyl alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Contact dermatitis in hairdressers' clients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The murine local lymph node assay: a commentary on collaborative studies and new directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The local lymph node assay: developments and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The local lymph node assay: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

A critical commentary and updating of the guinea pig maximization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Structure-activity relationships for skin sensitization: recent improvements to Derek for Windows.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Further evaluation of the local lymph node assay in the final phase of an international collaborative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The murine local lymph node assay: regulatory and potency considerations under REACH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Murine local lymph node assay for predictive testing of allergenicity: two irritants caused significant proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Contact dermatitis from cetostearyl alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Examination of a vehicle for use with water soluble materials in the murine local lymph node assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Testing for skin sensitization according to the notification procedure for new chemicals: the Magnusson and Kligman test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Permanent wave contact dermatitis: Contact allergy to glyceryl monothioglycolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

The local lymph node assay being too sensitive?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

A combined murine local lymph node and irritancy assay to predict sensitization and irritancy potential of chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.06.005

10.1016/J.YRTPH.2009.06.005

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference